Skip to main content
Top
Published in: International Journal of Colorectal Disease 10/2020

01-10-2020 | Crohn's Disease | Original Article

No effect of a liquid diet in the management of patients with stricturing Crohn’s disease

Authors: Irene Marafini, Silvia Salvatori, Edoardo Troncone, Patrizio Scarozza, Elisa Fantini, Giovanni Monteleone

Published in: International Journal of Colorectal Disease | Issue 10/2020

Login to get access

Abstract

Purpose

Patients with stricturing Crohn’s disease (CD) may experience episodes of intestinal sub-occlusions, which in many cases lead to surgery. The aim of this study was to examine whether adding a liquid diet to medical therapy could improve the management of patients with stricturing CD.

Methods

Medical records of CD outpatients with a small bowel stricture, either receiving (group 1) or not (group 2) a 24-h liquid diet every 10-14 days, were retrospectively analyzed. Number of sub-occlusive episodes, frequency, and timing of intestinal resections for strictures were analyzed.

Results

During the 12-month follow-up, there was no significant difference in the occurrence of new sub-occlusive episodes between the 2 groups (10/37 patients (27%) in group 1 vs 9/45 patients (20%) in group 2). Similarly, the number of patients undergoing bowel resections for sub-occlusive episodes non-responsive to medical therapy did not statistically differ between the two groups (9 patients (24.3%) in group 1 vs 7 patients (15.5%) in group 2). In group 1, surgeries were equally distributed along the 12-months of follow-up, while 85.7% of patients in group 2 underwent intestinal resection within the first 3 months of follow-up.

Conclusion

Adding a liquid diet to medical therapy does not help management of patients with stricturing CD.
Literature
1.
go back to reference Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L (2017) Crohn’s disease. Lancet 389:1741–1755CrossRef Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L (2017) Crohn’s disease. Lancet 389:1741–1755CrossRef
2.
go back to reference Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, el Yafi F, Colombel JF, Belaiche J (2003) Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52:552–557CrossRef Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, el Yafi F, Colombel JF, Belaiche J (2003) Early development of stricturing or penetrating pattern in Crohn’s disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52:552–557CrossRef
3.
go back to reference Zorzi F, Calabrese E, Monteleone G (2015) Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn’s disease. Clin Sci 129:1107–1113CrossRef Zorzi F, Calabrese E, Monteleone G (2015) Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn’s disease. Clin Sci 129:1107–1113CrossRef
4.
go back to reference Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert JP, Martinez de Guerenu B et al (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 34:125–145CrossRef Panes J, Bouzas R, Chaparro M, Garcia-Sanchez V, Gisbert JP, Martinez de Guerenu B et al (2011) Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 34:125–145CrossRef
5.
go back to reference Bettenworth D, Rieder F (2014) Medical therapy of stricturing Crohn’s disease: what the gut can learn from other organs - a systematic review. Fibrogenesis Tissue Repair 7:5CrossRef Bettenworth D, Rieder F (2014) Medical therapy of stricturing Crohn’s disease: what the gut can learn from other organs - a systematic review. Fibrogenesis Tissue Repair 7:5CrossRef
6.
go back to reference Di Sabatino A, Jackson CL, Pickard KM, Buckley M, Rovedatti L, Leakey NA et al (2009) Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut 58:777–789CrossRef Di Sabatino A, Jackson CL, Pickard KM, Buckley M, Rovedatti L, Leakey NA et al (2009) Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. Gut 58:777–789CrossRef
7.
go back to reference Franze E, Monteleone I, Laudisi F, Rizzo A, Dinallo V, Di Fusco D et al (2019) Cadherin-11 is a Regulator of intestinal fibrosis. J Crohn’s Colitis Franze E, Monteleone I, Laudisi F, Rizzo A, Dinallo V, Di Fusco D et al (2019) Cadherin-11 is a Regulator of intestinal fibrosis. J Crohn’s Colitis
8.
go back to reference Murthy SK, Begum J, Benchimol EI, Bernstein CN, Kaplan GG, McCurdy JD et al (2019) Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study. Gut Murthy SK, Begum J, Benchimol EI, Bernstein CN, Kaplan GG, McCurdy JD et al (2019) Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study. Gut
9.
go back to reference Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP (2005) Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 54:237–241CrossRef Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP (2005) Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 54:237–241CrossRef
10.
go back to reference Spinelli A, Correale C, Szabo H, Montorsi M (2010) Intestinal fibrosis in Crohn’s disease: medical treatment or surgery? Curr Drug Targets 11:242–248CrossRef Spinelli A, Correale C, Szabo H, Montorsi M (2010) Intestinal fibrosis in Crohn’s disease: medical treatment or surgery? Curr Drug Targets 11:242–248CrossRef
11.
go back to reference Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A et al (2016) European Crohn’s and colitis organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohn's Colitis 10:873–885CrossRef Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A et al (2016) European Crohn’s and colitis organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohn's Colitis 10:873–885CrossRef
12.
go back to reference Hansen T, Duerksen DR (2018) Enteral nutrition in the management of pediatric and adult Crohn’s disease. Nutrients 10 Hansen T, Duerksen DR (2018) Enteral nutrition in the management of pediatric and adult Crohn’s disease. Nutrients 10
13.
go back to reference Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140:1785–1794CrossRef Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140:1785–1794CrossRef
14.
go back to reference Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, Adamina M, Armuzzi A, Bachmann O, Bager P, Biancone L, Bokemeyer B, Bossuyt P, Burisch J, Collins P, el-Hussuna A, Ellul P, Frei-Lanter C, Furfaro F, Gingert C, Gionchetti P, Gomollon F, González-Lorenzo M, Gordon H, Hlavaty T, Juillerat P, Katsanos K, Kopylov U, Krustins E, Lytras T, Maaser C, Magro F, Kenneth Marshall J, Myrelid P, Pellino G, Rosa I, Sabino J, Savarino E, Spinelli A, Stassen L, Uzzan M, Vavricka S, Verstockt B, Warusavitarne J, Zmora O, Fiorino G (2020) ECCO Guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohn’s Colitis 14:4–22CrossRef Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, Adamina M, Armuzzi A, Bachmann O, Bager P, Biancone L, Bokemeyer B, Bossuyt P, Burisch J, Collins P, el-Hussuna A, Ellul P, Frei-Lanter C, Furfaro F, Gingert C, Gionchetti P, Gomollon F, González-Lorenzo M, Gordon H, Hlavaty T, Juillerat P, Katsanos K, Kopylov U, Krustins E, Lytras T, Maaser C, Magro F, Kenneth Marshall J, Myrelid P, Pellino G, Rosa I, Sabino J, Savarino E, Spinelli A, Stassen L, Uzzan M, Vavricka S, Verstockt B, Warusavitarne J, Zmora O, Fiorino G (2020) ECCO Guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohn’s Colitis 14:4–22CrossRef
15.
go back to reference Korelitz BI (2000) The role of liquid diet in the management of small bowel Crohn’s disease. Inflamm Bowel Dis 6:66–67 discussion 8-9CrossRef Korelitz BI (2000) The role of liquid diet in the management of small bowel Crohn’s disease. Inflamm Bowel Dis 6:66–67 discussion 8-9CrossRef
16.
go back to reference Bettenworth D, Bokemeyer A, Baker M, Mao R, Parker CE, Nguyen T, Ma C, Panés J, Rimola J, Fletcher JG, Jairath V, Feagan BG, Rieder F (2019) Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut 68:1115–1126CrossRef Bettenworth D, Bokemeyer A, Baker M, Mao R, Parker CE, Nguyen T, Ma C, Panés J, Rimola J, Fletcher JG, Jairath V, Feagan BG, Rieder F (2019) Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut 68:1115–1126CrossRef
Metadata
Title
No effect of a liquid diet in the management of patients with stricturing Crohn’s disease
Authors
Irene Marafini
Silvia Salvatori
Edoardo Troncone
Patrizio Scarozza
Elisa Fantini
Giovanni Monteleone
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 10/2020
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-020-03650-7

Other articles of this Issue 10/2020

International Journal of Colorectal Disease 10/2020 Go to the issue